BRAINCOOL AB (5YL) - Net Assets
Based on the latest financial reports, BRAINCOOL AB (5YL) has net assets worth €167.46 Million EUR (≈ $195.78 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€177.67 Million ≈ $207.72 Million USD) and total liabilities (€10.21 Million ≈ $11.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See BRAINCOOL AB (5YL) balance sheet quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €167.46 Million |
| % of Total Assets | 94.25% |
| Annual Growth Rate | 40.41% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 62.43 |
BRAINCOOL AB - Net Assets Trend (2021–2025)
This chart illustrates how BRAINCOOL AB's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of BRAINCOOL AB.
Annual Net Assets for BRAINCOOL AB (2021–2025)
The table below shows the annual net assets of BRAINCOOL AB from 2021 to 2025. Also explore 5YL net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €175.80 Million ≈ $205.53 Million |
+20.47% |
| 2024-12-31 | €145.93 Million ≈ $170.61 Million |
+30.60% |
| 2023-12-31 | €111.74 Million ≈ $130.63 Million |
-3.87% |
| 2022-12-31 | €116.23 Million ≈ $135.89 Million |
+156.98% |
| 2021-12-31 | €45.23 Million ≈ $52.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BRAINCOOL AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 36923830300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €583.79 Million | 332.07% |
| Total Equity | €175.80 Million | 100.00% |
BRAINCOOL AB Competitors by Market Cap
The table below lists competitors of BRAINCOOL AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Clarkson
LSE:CKN
|
$18.88 Million |
|
Australian Vintage Ltd
AU:AVG
|
$18.88 Million |
|
Ever Shine Textile Industry
JK:ESTI
|
$18.89 Million |
|
Kumpulan H & L High-Tech Bhd
KLSE:7033
|
$18.91 Million |
|
Orpheus Uranium Ltd
AU:ORP
|
$18.87 Million |
|
Ecolomondo Corp
V:ECM
|
$18.87 Million |
|
Woojin I&S Co Ltd
KO:010400
|
$18.86 Million |
|
Lancashire Holdings Ltd
LSE:LRE
|
$18.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BRAINCOOL AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 145,930,990 to 175,802,000, a change of 29,871,010 (20.5%).
- Net loss of 37,050,313 reduced equity.
- New share issuances of 67,331,149 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-37.05 Million | -21.08% |
| Share Issuances | €67.33 Million | +38.3% |
| Other Changes | €-409.83K | -0.23% |
| Total Change | €- | 20.47% |
Book Value vs Market Value Analysis
This analysis compares BRAINCOOL AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.17x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.45 | €0.08 | x |
| 2022-12-31 | €0.59 | €0.08 | x |
| 2023-12-31 | €0.52 | €0.08 | x |
| 2024-12-31 | €0.56 | €0.08 | x |
| 2025-12-31 | €0.45 | €0.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BRAINCOOL AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -21.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -102.31%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 1.09x
- Recent ROE (-21.08%) is above the historical average (-46.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -85.67% | -418.27% | 0.09x | 2.20x | €-43.27 Million |
| 2022 | -39.24% | -259.34% | 0.13x | 1.15x | €-57.24 Million |
| 2023 | -54.84% | -263.81% | 0.17x | 1.19x | €-72.45 Million |
| 2024 | -30.32% | -110.71% | 0.25x | 1.11x | €-58.83 Million |
| 2025 | -21.08% | -102.31% | 0.19x | 1.09x | €-54.63 Million |
Industry Comparison
This section compares BRAINCOOL AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $41,440,199,849
- Average return on equity (ROE) among peers: -12.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BRAINCOOL AB (5YL) | €167.46 Million | -85.67% | 0.06x | $18.88 Million |
| LEPU MED.T.B. SP.GDR O.N. (07Z0) | $17.76 Billion | 5.42% | 0.47x | $157.40K |
| BIORETEC OY (0TN) | $9.74 Million | -47.38% | 0.18x | $16.10 Million |
| SYSMEX CORP.UNSP.ADR 1/2 (0YX0) | $349.05 Billion | 12.63% | 0.39x | $4.70 Billion |
| INMODE LTD IS -01 (154) | $703.81 Million | 25.76% | 0.12x | $711.77 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $28.30 Million |
| Medtronic PLC (2M6) | $1.33 Billion | 22.02% | 0.46x | $83.04 Billion |
| Peijia Medical Limited (4WO) | $1.86 Billion | -10.94% | 0.43x | $401.71 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.22 Billion | -2.23% | 0.20x | $107.57 Million |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more